Endometrial Carcinoma — Trials

Endometrial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

325 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 109
Recruiting: 52
Ph III recruiting: 4
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 51–100 of 146 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04576104	Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer	active not recruiting	Phase 2	51	Northwestern UniversityOTHER	1	Jan 21, 2026	clinicaltrials
NCT06518564	Avelumab and M1774 in ARID1A-mutated Endometrial Cancer	recruiting	Phase 2	25	Panagiotis Konstantinopoulos, MD, PhDOTHER	1	Jan 7, 2026	clinicaltrials